Nuvation Bio Inc
NYSE:NUVB
Nuvation Bio Inc
NYSE:NUVB
Price:
4.51
USD
1.35%
Market Closed
Market Cap:
$1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nuvation Bio Inc
NYSE:NUVB
|
US |
|
V
|
Visa Inc
XETRA:3V64
|
US |
|
Annica Holdings Ltd
SGX:5AL
|
SG |
|
Cycliq Group Ltd
ASX:CYQ
|
AU |
|
S
|
SBM Offshore NV
VSE:SBMO
|
NL |
|
J
|
Jash Engineering Ltd
NSE:JASH
|
IN |
|
Atrium Ljungberg AB
STO:ATRLJ B
|
SE |
|
Bechtle AG
XETRA:BC8
|
DE |
|
S
|
Sufrin Holdings Ltd
TASE:SFRN
|
IL |
|
M
|
Manutan International SA
LSE:0F6I
|
FR |
|
Kaisun Holdings Ltd
HKEX:8203
|
HK |
Multiples-Based Value
The
Multiples-Based Value for
Nuvation Bio Inc (NUVB)
under the Base Case is
hidden
USD.
Compared with the current market price of 4.51 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NUVB Multiples-Based Value
LOCKED
Multiples Across Competitors
NUVB Competitors Multiples
Nuvation Bio Inc Competitors
Nuvation Bio Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Nuvation Bio Inc
NYSE:NUVB
|
1.6B USD | 24.8 | -7.6 | -5.8 | -5.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD | 13.5 | 42.6 | 28.8 | 30.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD | 4.5 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD | 2.4 | 16.5 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
